- Telehealth visits
Nicole W. Kittler, MD
She | Her | HersPediatric Dermatology- Telehealth visits
Nicole W. Kittler, MD
She | Her | HersPediatric Dermatology- Telehealth visits
On this page
About me
Dr. Nicole W. Kittler is a pediatric dermatologist who cares for infants, children and adolescents with skin conditions or vascular anomalies (abnormalities of veins or arteries). She performs minor surgical procedures, including laser surgery, and provides care in all settings – the clinic, hospital and emergency department. She collaborates with colleagues in other specialties to ensure her patients receive well-rounded treatment.
After earning her medical degree at Columbia University Vagelos College of Physicians and Surgeons, Kittler completed a residency in dermatology and served as chief resident at New York – Presbyterian/Columbia University Irving Medical Center. She completed a fellowship in pediatric dermatology at UCSF.
Education & training
Board certification
- Pediatric Dermatology, American Board of Dermatology
- Dermatology, American Board of Dermatology
Fellowship
- Dermatology, University of CA at San Francisco- Dermatology GME
Residency
- Dermatology, Columbia University Medical Center GME
Internship
- Pediatrics, Icahn School of Medicine at Mount Sinai
Degree
- MD, Columbia University, Vagelos College of Physicians & Surgeons
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Pediatric Psoriasis ComorbiditiesOpens in a new window
November 1, 2020
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.